Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA - Fox Business

As reported by Fox Business

Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg, distributed nationwide after testing found the medication could be more potent than intended

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Fox Business ↗

Market Samachar is a news aggregator. This article was originally published by Fox Business. Tap the button above to read the full story on their site.

INDIAN Nvidia’s 70% sales growth forecast sends a message to AI doubters. What did CEO Jensen Huang say? Markets-Economic Times
INDIAN Augmont Enterprises IPO allotment today; GMP at 40% hints at strong listing. Here’s how to check status Markets-Economic Times
INDIAN ETMarkets Smart Talk | Two-year market consolidation may set stage for next bull run: UTI AMC’s Ajay Tyagi Markets-Economic Times
COMPANIES India equity outlook cut again as foreign funds seek value elsewhere in Asia Stocks-Markets-Economic Times
COMPANIES Stock split alert! Last day to buy 2 multibagger microcap stocks which rallied up to 540% in a year Stocks-Markets-Economic Times
COMPANIES Dividend alert! Last day to buy Paras Defence, MCX, Honasa among 33 stocks for dividend rewards. Do you own any? Stocks-Markets-Economic Times
INDIAN RBI is showing up whenever rupee weakens in intervention shift Markets-Economic Times
INDIAN Lumino Industries IPO opens today: GMP signals 61% listing gains — Should you subscribe? Markets-Economic Times

Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA - Fox Business

More from Market Samachar